146 related articles for article (PubMed ID: 14598417)
1. Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer.
McDonnell CO; Bouchier-Hayes DJ; Toomey D; Foley D; Kay EW; Leen E; Walsh TN
Br J Surg; 2003 Nov; 90(11):1373-8. PubMed ID: 14598417
[TBL] [Abstract][Full Text] [Related]
2. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
McDonnell CO; Harmey JH; Bouchier-Hayes DJ; Walsh TN
Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797
[TBL] [Abstract][Full Text] [Related]
3. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer.
Courrech Staal EF; Aleman BM; Boot H; van Velthuysen ML; van Tinteren H; van Sandick JW
Br J Surg; 2010 Oct; 97(10):1482-96. PubMed ID: 20645400
[TBL] [Abstract][Full Text] [Related]
5. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer.
van Heijl M; Phoa SS; van Berge Henegouwen MI; Omloo JM; Mearadji BM; Sloof GW; Bossuyt PM; Hulshof MC; Richel DJ; Bergman JJ; Ten Kate FJ; Stoker J; van Lanschot JJ
Eur J Surg Oncol; 2011 Dec; 37(12):1064-71. PubMed ID: 21944048
[TBL] [Abstract][Full Text] [Related]
6. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer.
Geh JI; Crellin AM; Glynne-Jones R
Br J Surg; 2001 Mar; 88(3):338-56. PubMed ID: 11260097
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma.
Torres C; Wang H; Turner J; Shahsafaei A; Odze RD
Hum Pathol; 1999 Jul; 30(7):753-8. PubMed ID: 10414493
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
11. [Predictive factors in esophageal cancer after neoadjuvant therapy].
Bognár G; Ledniczky G; Imdahl A; Ihling C; Ondrejka P
Magy Seb; 2006 Feb; 59(1):20-6. PubMed ID: 16637386
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
Tanaka A; Ishikawa S; Okuno K; Shiozaki H
Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
[TBL] [Abstract][Full Text] [Related]
13. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
Sjoquist KM; Burmeister BH; Smithers BM; Zalcberg JR; Simes RJ; Barbour A; Gebski V;
Lancet Oncol; 2011 Jul; 12(7):681-92. PubMed ID: 21684205
[TBL] [Abstract][Full Text] [Related]
14. Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?
Shaukat A; Mortazavi A; Demmy T; Nava H; Wilkinson N; Yang G; Kepner J; Javle M
Dis Esophagus; 2004; 17(2):129-35. PubMed ID: 15230725
[TBL] [Abstract][Full Text] [Related]
15. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
16. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
17. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
Makary MA; Kiernan PD; Sheridan MJ; Tonnesen G; Hetrick V; Vaughan B; Graling P; Elster E
Am Surg; 2003 Aug; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
[TBL] [Abstract][Full Text] [Related]
18. [The effect of preoperative chemo-radiotherapy in the treatment of locally advanced squamous cell carcinoma in the upper- and middle-thirds of the esophagus].
Papp A; Cseke L; Pavlovics G; Farkas R; Varga G; Márton S; Pótó L; Esik O; Horváth OP
Magy Seb; 2007; 60(3):123-9. PubMed ID: 17727214
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma.
Kimura S; Kitadai Y; Tanaka S; Kuwai T; Hihara J; Yoshida K; Toge T; Chayama K
Eur J Cancer; 2004 Aug; 40(12):1904-12. PubMed ID: 15288294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]